Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Rubitecan (RFS 2000) in Soft-Tissue Sarcomas
NCT00005874Phase 2Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Jun 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rubitecan in soft tissue sarcoma (STS), gastrointestinal stromal tumor (GIST), sponsored by Astex Pharmaceuticals. Started Jun 1999; status: completed.
02
Drugs
rubitecan
03
Conditions
soft tissue sarcoma (STS)gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00005874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005874.